Atossa Historical Income Statement

ATOS Stock  USD 1.28  0.01  0.78%   
Historical analysis of Atossa Genetics income statement accounts such as Interest Expense of 8.7 K, Selling General Administrative of 8.7 M or Selling And Marketing Expenses of 16.9 M can show how well Atossa Genetics performed in making a profits. Evaluating Atossa Genetics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Atossa Genetics's future profits or losses.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Atossa Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atossa Genetics is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

About Atossa Income Statement Analysis

Atossa Genetics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Atossa Genetics shareholders. The income statement also shows Atossa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Atossa Genetics Income Statement Chart

At this time, Atossa Genetics' Selling And Marketing Expenses is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 32.9 M in 2024, whereas Interest Expense is likely to drop 8,740 in 2024.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Atossa Genetics income statement and is an important metric when analyzing Atossa Genetics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Atossa Genetics minus its cost of goods sold. It is profit before Atossa Genetics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Atossa Genetics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Atossa Genetics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.At this time, Atossa Genetics' Selling And Marketing Expenses is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 32.9 M in 2024, whereas Interest Expense is likely to drop 8,740 in 2024.
 2023 2024 (projected)
Interest Income3.8M4.0M
Non Recurring415.5K394.8K

Atossa Genetics income statement Correlations

-0.170.0-0.45-0.250.220.25-0.440.27-0.270.23-0.30.230.310.250.910.280.110.310.44-0.22-0.25-0.30.58
-0.17-0.030.24-0.020.020.020.020.02-0.02-0.08-0.73-0.170.57-0.08-0.17-0.07-0.83-0.28-0.24-0.17-0.12-0.28-0.16
0.0-0.030.550.85-0.88-0.880.74-0.870.84-0.880.2-0.87-0.080.06-0.16-0.850.13-0.41-0.580.410.460.47-0.71
-0.450.240.550.65-0.65-0.660.7-0.660.66-0.660.21-0.64-0.34-0.42-0.46-0.640.13-0.76-0.90.520.40.46-0.77
-0.25-0.020.850.65-1.0-1.00.97-1.01.0-0.990.35-0.97-0.210.01-0.38-0.980.19-0.34-0.610.720.690.8-0.86
0.220.02-0.88-0.65-1.01.0-0.961.0-1.00.99-0.320.980.190.00.360.99-0.190.360.62-0.7-0.67-0.770.86
0.250.02-0.88-0.66-1.01.0-0.971.0-1.00.99-0.350.980.210.010.370.99-0.190.360.62-0.71-0.68-0.770.87
-0.440.020.740.70.97-0.96-0.97-0.970.97-0.960.38-0.93-0.28-0.06-0.52-0.970.18-0.34-0.630.760.720.83-0.9
0.270.02-0.87-0.66-1.01.01.0-0.97-1.00.99-0.350.970.210.020.390.99-0.190.370.63-0.71-0.68-0.770.88
-0.27-0.020.840.661.0-1.0-1.00.97-1.0-0.990.36-0.97-0.210.0-0.39-0.980.19-0.35-0.620.730.690.8-0.87
0.23-0.08-0.88-0.66-0.990.990.99-0.960.99-0.99-0.220.990.1-0.020.380.99-0.080.380.63-0.65-0.64-0.720.87
-0.3-0.730.20.210.35-0.32-0.350.38-0.350.36-0.22-0.16-0.81-0.19-0.18-0.240.81-0.04-0.190.580.460.61-0.26
0.23-0.17-0.87-0.64-0.970.980.98-0.930.97-0.970.99-0.160.00.00.390.980.00.410.65-0.62-0.62-0.680.86
0.310.57-0.08-0.34-0.210.190.21-0.280.21-0.210.1-0.810.00.140.090.12-0.76-0.030.09-0.47-0.31-0.440.26
0.25-0.080.06-0.420.010.00.01-0.060.020.0-0.02-0.190.00.140.110.0-0.210.570.52-0.16-0.02-0.010.08
0.91-0.17-0.16-0.46-0.380.360.37-0.520.39-0.390.38-0.180.390.090.110.410.150.40.52-0.23-0.28-0.330.64
0.28-0.07-0.85-0.64-0.980.990.99-0.970.99-0.980.99-0.240.980.120.00.41-0.080.340.6-0.66-0.66-0.740.88
0.11-0.830.130.130.19-0.19-0.190.18-0.190.19-0.080.810.0-0.76-0.210.15-0.080.01-0.050.480.280.440.02
0.31-0.28-0.41-0.76-0.340.360.36-0.340.37-0.350.38-0.040.41-0.030.570.40.340.010.92-0.060.080.010.48
0.44-0.24-0.58-0.9-0.610.620.62-0.630.63-0.620.63-0.190.650.090.520.520.6-0.050.92-0.39-0.3-0.350.7
-0.22-0.170.410.520.72-0.7-0.710.76-0.710.73-0.650.58-0.62-0.47-0.16-0.23-0.660.48-0.06-0.390.890.94-0.53
-0.25-0.120.460.40.69-0.67-0.680.72-0.680.69-0.640.46-0.62-0.31-0.02-0.28-0.660.280.08-0.30.890.92-0.51
-0.3-0.280.470.460.8-0.77-0.770.83-0.770.8-0.720.61-0.68-0.44-0.01-0.33-0.740.440.01-0.350.940.92-0.6
0.58-0.16-0.71-0.77-0.860.860.87-0.90.88-0.870.87-0.260.860.260.080.640.880.020.480.7-0.53-0.51-0.6
Click cells to compare fundamentals

Atossa Genetics Account Relationship Matchups

Atossa Genetics income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization44.2K52.8K46.6K23K8K21.9K
Selling General Administrative10.6M8.0M11.3M12.6M14.0M8.7M
Other Operating Expenses17.3M14.6M20.5M27.7M31.4M32.9M
Operating Income(17.3M)(14.6M)(20.5M)(27.7M)(31.4M)(29.8M)
Ebit(17.3M)(14.6M)(20.5M)(27.7M)(31.4M)(29.8M)
Research Development6.6M6.6M9.2M15.1M17.3M18.2M
Ebitda(17.2M)(14.6M)(20.5M)(27.7M)(31.4M)(29.8M)
Total Operating Expenses17.3M14.6M20.5M27.7M31.4M32.9M
Income Before Tax(17.2M)(17.8M)(20.6M)(27.0M)(30.1M)(28.6M)
Total Other Income Expense Net25.6K(3.2M)(85K)731K1.3M1.3M
Net Income(17.2M)(21.1M)(20.6M)(26.2M)(30.1M)(28.6M)
Income Tax Expense(119.1K)3.3M(213.6K)(731K)(840.7K)(798.6K)
Gross Profit(44.2K)(52.8K)(46.6K)(23K)(8K)(21.9K)
Cost Of Revenue44.2K52.8K46.6K23K8K21.9K
Net Income From Continuing Ops(17.2M)(17.8M)(20.6M)(27.0M)(29.8M)(28.3M)
Non Operating Income Net Other25.6K(2.3M)(85K)731K657.9K690.8K
Net Income Applicable To Common Shares(17.2M)(22.3M)(20.6M)(27.0M)(24.3M)(25.5M)
Reconciled Depreciation52.8K46.5K23K8K11K10.5K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.